Tobacco smoking and risk of bladder cancer
- PMID: 18815916
- DOI: 10.1080/03008880802283664
Tobacco smoking and risk of bladder cancer
Abstract
Tobacco smoking is the main known cause of urinary bladder cancer in humans. In most populations, over half of cases in men and a sizeable proportion in women are attributable to this habit. Epidemiological studies conducted in different populations have shown a linear relationship between intensity and duration of smoking and risk. Quitting smoking reduces the risk of bladder cancer. Smoking black (air-cured) cigarettes results in a higher risk than smoking blond (flue-cured) tobacco cigarettes; results on inhalation patterns and use of filter are not consistent. Cigar and pipe smoking also increases the risk of bladder cancer; data on other tobacco products are limited. The evidence for non-transitional bladder carcinoma is limited, but consistent with an increased risk. The available evidence does not point towards a different carcinogenic effect of tobacco smoking in men and women or in whites and blacks. Data on involuntary smoke and use of smokeless tobacco products are limited, but do not suggest an increased risk of bladder cancer.
Similar articles
-
Nonsmoking-related arylamine exposure and bladder cancer risk.Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12814994
-
Effects of timing and type of tobacco in cigarette-induced bladder cancer.Cancer Res. 1988 Jul 1;48(13):3849-52. Cancer Res. 1988. PMID: 3378220
-
Coffee and alcohol consumption and bladder cancer.Scand J Urol Nephrol Suppl. 2008 Sep;(218):37-44. doi: 10.1080/03008880802237090. Scand J Urol Nephrol Suppl. 2008. PMID: 18815915 Review.
-
Epidemiological models of carcinogenesis: the example of bladder cancer.Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):149-53. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1306098 Review.
-
Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.Eur J Cancer. 1993;29A(8):1199-207. doi: 10.1016/s0959-8049(05)80315-6. Eur J Cancer. 1993. PMID: 8518034 Review.
Cited by
-
Alterations of DNA methylome in human bladder cancer.Epigenetics. 2013 Oct;8(10):1013-22. doi: 10.4161/epi.25927. Epub 2013 Aug 6. Epigenetics. 2013. PMID: 23975266 Free PMC article. Review.
-
Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries.Cancer Control. 2018 Jan-Dec;25(1):1073274818789359. doi: 10.1177/1073274818789359. Cancer Control. 2018. PMID: 30027755 Free PMC article.
-
Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model.Toxicol Appl Pharmacol. 2010 Apr 15;244(2):162-73. doi: 10.1016/j.taap.2009.12.029. Epub 2010 Jan 4. Toxicol Appl Pharmacol. 2010. PMID: 20045430 Free PMC article.
-
Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.Toxicol Appl Pharmacol. 2012 Jan 1;258(1):10-8. doi: 10.1016/j.taap.2011.10.002. Epub 2011 Oct 10. Toxicol Appl Pharmacol. 2012. PMID: 22015448 Free PMC article.
-
Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes.Front Pharmacol. 2024 Jan 12;14:1326627. doi: 10.3389/fphar.2023.1326627. eCollection 2023. Front Pharmacol. 2024. PMID: 38283839 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical